Les présentations du congrès bénéficiant d'une autorisation de diffusion sont consultables sur le programme ci-après en cliquant sur le pictogramme en forme d'écran.
Update on heart failure drugs - including Vericiguat
E. VERMES
Surgical treatment of atrial fi brillation in heart failure
M. LA MEIR
Advanced heart failure monitoring with cardiomems
P. DEGROOTE
New guidelines on the management of the heart transplanted patient
G. COUTANCE
Heart transplantation for patients over 70 years old
R. DORENT
Update from the Biomedecine agency. Thoracic organs transplantation in 2021
R. DORENT
Clinical case. Acute cardiac graft dysfunction: next step after normal biopsy and coronary angiography?
L. LECUYER
Skin cancers in heart transplanted patients: really a problem in 2022?
S. BARETE
Top Chef in heart transplant
E. EPAILLY
Lung transplant allocation - Today and tomorrow, here and elsewhere
J. MESSIKA
Impact of changing cardiac graft allocation policy on the profi le of heart transplant candidates and transplanted patients. La Pitié experience
E. DESIRE
Impact of new heart allocation policy in US
W. PARKER
Summary of ISHLT guidelines
M. KITTLESON
Lung Transplantation
C. PICARD
Christel’s register
A. HERTIG
Update inolecular biology data in heart transplantation
A. GIARRAPUTO
Impact of organ donor characteristics on predictive models for post cardiac transplantation outcome
M. LESCROART
Results of the miRRACLE study (non-invasive screening of cardiac allograft rejection by circulating microRNA assay)
G. COUTANCE
INFECTIOUS COMPLICATIONS AFTER HEART TRANSPLANTATION
09.00 - 10.30
Recurrent infections in a heart transplanted patient: case report
L. LECUYER
Main issue - the nurse key role
S. JAMET
The main issues with the immunocompromised patient
Y. TAMZALI
Vaccinations before and after heart transplantation
F. HAZAN
Preventing infections in transplanted patients
M. LESCROART
Thoracic organs transplantation in 2021
R. DORENT
Clinical case: When anticipating is associated with success
O. CAZIMAJOU, J. PERRIN
Heart failure and pregnancy: the cardiologist point of view
L. LEGRAND
Heart failure and pregnancy: the obstetrician point of view
J. NIZARD
Pregnancy and heart transplantation: clinical experience
E. DESIRE
SHORT AND LONG TERM MECHANICAL CIRCULATORY SUPPORTS
13.30 - 15.15
HM6 et assistance biventriculaire / coeur artificiel total
A. LABOURE, C. DE ARAUJO, G. LEBRETON
Impella in operating room
E. BERG, G. LEBRETON
Impella in intensive care
J. GICQUEL, A. PEUCH
Equipe dédiée choc cardiogénique : Impact pronostic
C. SORBIER, A. OUATTARA
Perfusion de greffons cardiaques Xvivo
P. LE GLOAHEC, T. ROY, G. LEBRETON
THINGS ARE MOVING IN HEART TRANSPLANTATION
15.45 - 18.00
Fewer and fewer contra-indications?
E. DESIRE
Towards an individualized follow-up?
G. COUTANCE
First update of the remote monitoring of heart transplant patients at La Pitié
E. COCHAT, Y. BLACODON
Curative treatments of COVID in heart transplant patients: organization, management, indications
F. HAZAN, L. GASPARD
From France to the United States via Mexico. My story as a heart transplanted patient
M. Guillaume SIMON
La Pitié association of transplanted patients
J. CAMUS
Transforme update
C. AMREIN
Update on cardiac Xenotransplantation
P. LEPRINCE
Anchor trial and other randomized trials: progress report
A. COMBES
ECMO VA and Covid
G. HEKIMIAN
ECMO in pulmonary embolism
O. SANCHEZ
Replacement of ECMO membranes: indications and results
T. GENTY
Predicting the potential for recovery upon implementation of temporary assistance?
A. OUATTARA
ECI-BLAD study
A . QUESSARD
Use of Cytosorb during cardiac transplantation
E. NEMETH
Impella and VSD
C.-H. DAVID
AMBUVAD study update
G. BAUDRY
HMIII and outcome heterogeneity in Momentum trial
N. URIEL
Post LVAD transplantation: benefit or risk?
M. DUMONT
HM3 in smaller patients
N. D’OSTREVY
Biventricular HM3: Australian experience
D. McGIFFIN
HM3: 5 year outcome (Momentum trial)
N. URIEL
Percutaneous drive-line care: review of procedures in France
M. Le BIDAN
Euromacs update
K. VEEN
Francemacs update
M. KINDO